Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Hepion Pharmaceuticals(HEPA) the EBIT is -1.211 M (+9.78%);the EPS is -0.0771 (+16.24%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B9.78%
----
----
EPS
-0.077116.24%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf